|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14/08 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 14/08 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 25.63L 22.54L 21.32L 19.33L 36.31L 25Cr 36.52L 2.55Cr 98.57L 13Cr 96.23L 94.15L 40Cr | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44Cr 2.15Cr 2.03Cr 1.84Cr 3.46Cr 234.38Cr 3.48Cr 24Cr 9.39Cr 119.6Cr 9.17Cr 8.97Cr 384.33Cr | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.46% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 21/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 16/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 01/04/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 21/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 21/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | +0.39% | +61.69% | +118.70% | 1,05600Cr | |
| -2.00% | -0.77% | +47.08% | +71.51% | 66TCr | |
| -1.34% | -0.81% | +17.88% | +76.48% | 47TCr | |
| -1.72% | -4.06% | +36.39% | +39.47% | 34TCr | |
| -0.40% | +3.83% | +22.08% | +28.82% | 28TCr | |
| -0.51% | -1.93% | +12.09% | +11.94% | 26TCr | |
| -0.32% | +1.74% | +52.34% | +55.29% | 23TCr | |
| -1.71% | -2.31% | +32.43% | +99.01% | 19TCr | |
| -0.24% | -2.76% | -28.41% | -60.92% | 17TCr | |
| Average | -0.99% | +0.97% | +28.18% | +48.92% | 40.48TCr | |
| Weighted average by Cap. | -1.11% | +1.04% | +38.22% | +69.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.85Cr 2.51Cr 2.37Cr 2.15Cr 4.04Cr 273.93Cr 4.07Cr 28Cr 11Cr 139.78Cr 11Cr 10Cr 449.18Cr | 2.07Cr 1.82Cr 1.72Cr 1.56Cr 2.93Cr 198.82Cr 2.95Cr 21Cr 7.97Cr 101.45Cr 7.78Cr 7.61Cr 326.01Cr |
| Net income | -3.93Cr -3.45Cr -3.26Cr -2.96Cr -5.56Cr -376.84Cr -5.59Cr -39Cr -15Cr -192.29Cr -15Cr -14Cr -617.93Cr | -4.81Cr -4.23Cr -4Cr -3.63Cr -6.81Cr -461.32Cr -6.85Cr -48Cr -18Cr -235.4Cr -18Cr -18Cr -756.45Cr |
| Net Debt | 60.5L 53.21L 50.32L 45.64L 85.71L 58Cr 86.21L 6.02Cr 2.33Cr 30Cr 2.27Cr 2.22Cr 95Cr | 2.19Cr 1.92Cr 1.82Cr 1.65Cr 3.1Cr 209.78Cr 3.11Cr 22Cr 8.4Cr 107.05Cr 8.2Cr 8.03Cr 343.99Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
